ImageneBio, Inc. Shareholders' Equity
ImageneBio, Inc. (IMA) had Shareholders' Equity of $142.07 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $142.07M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $123.33M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $133.14M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $139.83M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $142.07M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $123.33M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $133.14M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $139.83M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$180.35M 10-Q · filed 2026-08-05 | $115.91M 10-Q · filed 2025-07-24 |
| 2025-03-31 | -$169.60M 10-Q · filed 2026-08-05 | $118.25M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$160.56M 10-Q · filed 2026-08-05 | $125.93M 10-K · filed 2025-03-06 |
| 2024-09-30 | -$152.75M 10-Q · filed 2025-11-12 | $134.23M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$146.57M 10-Q · filed 2025-11-12 | $142.86M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$137.35M 10-Q · filed 2025-11-12 | $155.35M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$126.11M 10-K · filed 2026-03-10 | $169.76M 10-K · filed 2024-03-12 |
| 2023-09-30 | $155.34M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $156.70M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $135.02M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $146.97M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $158.79M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $174.37M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $192.96M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $207.88M 10-K · filed 2024-03-12 | |
| 2021-09-30 | $203.26M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $216.26M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $227.64M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | -$101.05M 10-K · filed 2023-03-14 | |
| 2020-09-30 | -$78.50M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$72.70M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | -$68.01M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | -$61.46M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |